Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $7.00 target price on the stock. A number of other equities research analysts have also recently issued reports on the stock. Piper Sandler began coverage on […]
Taysha Gene Therapies (TSHA) to Release Earnings on Tuesday dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of "Buy" from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s share price was up 11.9% during mid-day trading on Thursday . The stock traded as high as $2.85 and last traded at $2.82. Approximately 326,018 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 1,794,341 shares. The stock had […]
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Free Report) dropped 9% during mid-day trading on Tuesday . The stock traded as low as $0.36 and last traded at $0.36. Approximately 6,106 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 199,464 shares. The stock had previously closed at […]